All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing and tracking COVID-19
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 2, 2021
Home
»
Authors
» Mark Lawson
Mark Lawson
Articles
ARTICLES
Court Documents Reveal GSK's Stand On Relenza
June 15, 2005
By
Mark Lawson
No Comments
Court Documents Reveal GSK's Stand On Relenza
June 15, 2005
By
Mark Lawson
No Comments
Investor Interest Wanes For Australia's Biotech Stocks
April 20, 2005
By
Mark Lawson
No Comments
Investor Interest Wanes For Australia's Biotech Stocks
April 20, 2005
By
Mark Lawson
No Comments
Australian Stock Exchange: Commissioned Reports OK
Feb. 9, 2005
By
Mark Lawson
No Comments
Australian Stock Exchange: Commissioned Reports OK
Feb. 9, 2005
By
Mark Lawson
No Comments
Metabolic Jumps, Slides On Trial Data, Analyst Criticism
Dec. 22, 2004
By
Mark Lawson
No Comments
Metabolic Jumps, Slides On Trial Data, Analyst Criticism
Dec. 22, 2004
By
Mark Lawson
No Comments
Peptech, J&J Unit Centocor Settle Remicade IP Dispute
Nov. 24, 2004
By
Mark Lawson
No Comments
Peptech, J&J Unit Centocor Settle Remicade IP Dispute
Nov. 24, 2004
By
Mark Lawson
No Comments
View All Articles by Mark Lawson